valsartan + amlodipine
Sponsors
Novartis
Conditions
HYPERTENSIONHypertension
Phase 3
A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension
CompletedNCT00170976
Start: 2004-04-30End: 2005-06-30Updated: 2023-10-12
8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
CompletedNCT00327587
Start: 2006-05-31End: 2007-08-31Updated: 2011-11-08
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
CompletedNCT00350168
Start: 2006-06-30End: 2007-04-30Updated: 2016-11-18
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
CompletedNCT00353912
Start: 2006-06-30End: 2007-04-30Updated: 2016-11-18
Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine
CompletedNCT00367939
Start: 2005-12-31End: 2006-07-31Updated: 2017-05-18
A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
CompletedNCT00392262
Start: 2006-08-31End: 2007-02-28Updated: 2016-11-18